3 Stocks Dragging In The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 21 points (0.1%) at 16,839 as of Wednesday, June 25, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,709 issues advancing vs. 1,282 declining with 166 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is up 0.2%. On the negative front, top decliners within the industry include Grifols ( GRFS), down 2.1%, Tenet Healthcare ( THC), down 1.9%, Icon ( ICLR), down 1.9% and Smith & Nephew ( SNN), down 0.9%. Top gainers within the industry include Medical Action Industries ( MDCI), up 93.6%, Align Technology ( ALGN), up 2.4%, CR Bard ( BCR), up 2.3%, Hologic ( HOLX), up 2.1% and Becton Dickinson ( BDX), up 1.0%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Catamaran ( CTRX) is one of the companies pushing the Health Services industry lower today. As of noon trading, Catamaran is down $0.39 (-0.9%) to $43.79 on light volume. Thus far, 673,679 shares of Catamaran exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $43.50-$44.24 after having opened the day at $44.11 as compared to the previous trading day's close of $44.18.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $9.1 billion and is part of the health care sector. Shares are down 6.9% year-to-date as of the close of trading on Tuesday. Currently there are 13 analysts that rate Catamaran a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, good cash flow from operations and compelling growth in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Catamaran Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Laboratory Corp of America Hldgs ( LH) is down $0.70 (-0.7%) to $101.50 on light volume. Thus far, 349,380 shares of Laboratory Corp of America Hldgs exchanged hands as compared to its average daily volume of 999,400 shares. The stock has ranged in price between $101.43-$103.20 after having opened the day at $102.15 as compared to the previous trading day's close of $102.20.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corp of America Hldgs has a market cap of $8.7 billion and is part of the health care sector. Shares are up 11.8% year-to-date as of the close of trading on Tuesday. Currently there are 6 analysts that rate Laboratory Corp of America Hldgs a buy, 2 analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Laboratory Corp of America Hldgs as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Laboratory Corp of America Hldgs Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, HCA Holdings ( HCA) is down $0.36 (-0.6%) to $56.18 on average volume. Thus far, 1.4 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $55.81-$57.44 after having opened the day at $56.48 as compared to the previous trading day's close of $56.54.

HCA Holdings, Inc., through its subsidiaries, provides health care services. HCA Holdings has a market cap of $25.6 billion and is part of the health care sector. Shares are up 18.5% year-to-date as of the close of trading on Tuesday. Currently there are 15 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates HCA Holdings as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and poor profit margins. Get the full HCA Holdings Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

3 Things Investors Must Know for Monday

3 Things Investors Must Know for Monday

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric